Literature DB >> 16629900

Regulation of mitotic function of Chk1 through phosphorylation at novel sites by cyclin-dependent kinase 1 (Cdk1).

Takashi Shiromizu1, Hidemasa Goto, Yasuko Tomono, Jiri Bartek, Go Totsukawa, Akihito Inoko, Makoto Nakanishi, Fumio Matsumura, Masaki Inagaki.   

Abstract

Chk1 is phosphorylated at Ser317 and Ser345 by ATR in response to stalled replication and genotoxic stresses. This Chk1 activation is thought to play critical roles in the prevention of premature mitosis. However, the behavior of Chk1 in mitosis remains largely unknown. Here we reported that Chk1 was phosphorylated in mitosis. The reduction of this phosphorylation was observed at the metaphase-anaphase transition. Two-dimensional phosphopeptide mapping revealed that Chk1 phosphorylation sites in vivo were completely overlapped with the in vitro sites by cyclin-dependent protein kinase (Cdk) 1 or by p38 MAP kinase. Ser286 and Ser301 were identified as novel phosphorylation sites on Chk1. Treatment with Cdk inhibitor butyrolactone I induced the reduction of Chk1-S301 phosphorylation, although treatment with p38-specific inhibitor SB203580 or siRNA did not. In addition, ionizing radiation (IR) or ultraviolet (UV) light did not induce Chk1 phosphorylation at Ser317 and Ser345 in nocodazole-arrested mitotic cells. These observations imply the regulation of mitotic Chk1 function through Chk1 phosphorylation at novel sites by Cdk1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16629900     DOI: 10.1111/j.1365-2443.2006.00955.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  24 in total

1.  Specific role of Chk1 phosphorylations in cell survival and checkpoint activation.

Authors:  Hiroyuki Niida; Yuko Katsuno; Birendranath Banerjee; M Prakash Hande; Makoto Nakanishi
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

2.  Chk1 is required for spindle checkpoint function.

Authors:  George Zachos; Elizabeth J Black; Mark Walker; Mary T Scott; Paola Vagnarelli; William C Earnshaw; David A F Gillespie
Journal:  Dev Cell       Date:  2007-02       Impact factor: 12.270

3.  Novel positive feedback loop between Cdk1 and Chk1 in the nucleus during G2/M transition.

Authors:  Masato Enomoto; Hidemasa Goto; Yasuko Tomono; Kousuke Kasahara; Kunio Tsujimura; Tohru Kiyono; Masaki Inagaki
Journal:  J Biol Chem       Date:  2009-10-16       Impact factor: 5.157

4.  p38α MAPK is a MTOC-associated protein regulating spindle assembly, spindle length and accurate chromosome segregation during mouse oocyte meiotic maturation.

Authors:  Xiang-Hong Ou; Sen Li; Bao-Zeng Xu; Zhen-Bo Wang; Song Quan; Mo Li; Qing-Hua Zhang; Ying-Chun Ouyang; Heide Schatten; Fu-Qi Xing; Qing-Yuan Sun
Journal:  Cell Cycle       Date:  2010-10-20       Impact factor: 4.534

Review 5.  Roles of Chk1 in cell biology and cancer therapy.

Authors:  Youwei Zhang; Tony Hunter
Journal:  Int J Cancer       Date:  2013-05-28       Impact factor: 7.396

6.  A novel protein kinase A-independent, beta-arrestin-1-dependent signaling pathway for p38 mitogen-activated protein kinase activation by beta2-adrenergic receptors.

Authors:  Kaizheng Gong; Zijian Li; Ming Xu; Jianhai Du; Zhizhen Lv; Youyi Zhang
Journal:  J Biol Chem       Date:  2008-08-04       Impact factor: 5.157

7.  Akt/PKB suppresses DNA damage processing and checkpoint activation in late G2.

Authors:  Naihan Xu; Nadia Hegarat; Elizabeth J Black; Mary T Scott; Helfrid Hochegger; David A Gillespie
Journal:  J Cell Biol       Date:  2010-08-02       Impact factor: 10.539

8.  Essential function of Chk1 can be uncoupled from DNA damage checkpoint and replication control.

Authors:  Deborah Wilsker; Eva Petermann; Thomas Helleday; Fred Bunz
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-17       Impact factor: 11.205

9.  Applying a targeted label-free approach using LC-MS AMT tags to evaluate changes in protein phosphorylation following phosphatase inhibition.

Authors:  Feng Yang; Navdeep Jaitly; Hemalatha Jayachandran; Quanzhou Luo; Matthew E Monroe; Xiuxia Du; Marina A Gritsenko; Rui Zhang; David J Anderson; Samuel O Purvine; Joshua N Adkins; Ronald J Moore; Heather M Mottaz; Shi-Jian Ding; Mary S Lipton; David G Camp; Harold R Udseth; Richard D Smith; Sandra Rossie
Journal:  J Proteome Res       Date:  2007-10-12       Impact factor: 4.466

10.  Tumor suppressor protein C53 antagonizes checkpoint kinases to promote cyclin-dependent kinase 1 activation.

Authors:  Hai Jiang; Jianchun Wu; Chen He; Wending Yang; Honglin Li
Journal:  Cell Res       Date:  2009-04       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.